← Open Payments lookup

MARTIN GUERRERO: Open Payments

NPI 1952591935 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$439,318 in 691 payments from 15 companies in 2025. Trend: 2023 $377,625 · 2024 $497,858 · 2025 $439,318

Speaker / faculty: $328,787Travel & lodging: $61,235Consulting: $18,803Food & beverage: $15,610Honoraria: $14,850Education: $33
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.216$168,014
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)137$87,168
Otsuka America Pharmaceutical, Inc.139$77,218
Neurocrine BioSciences, Inc.97$67,106
E.R. Squibb & Sons, L.L.C.30$18,720
Axsome Therapeutics, Inc.17$16,102
ABBVIE INC.21$2,723
Alkermes, Inc.5$481
Lundbeck LLC9$456
Teva Pharmaceuticals USA, Inc.5$376

Products named: FANAPT, CAPLYTA, REXULTI, INGREZZA, Auvelity, COBENFY, VRAYLAR, ARISTADA.

Industry payments across TX — which companies pay providers there.